On Friday, Green Plains Inc (NASDAQ:GPRE)’s shares declined -3.16% to $27.62.
Green Plains Partners LP declared the pricing of its initial public offering of 10,000,000 common units representing limited partner interests at a public offering price of $15.00 per common unit. The common units are predictable to start trading on the Nasdaq Global Market under the ticker symbol “GPP” on June 26, 2015. In addition, Green Plains Partners has granted the underwriters an option to purchase up to an additional 1,500,000 common units at the initial public offering price. The offering is predictable to close on July 1, 2015, subject to the satisfaction of customary closing conditions.
Green Plains Inc. produces, markets, and distributes ethanol in the United States. The company operates through four segments: Ethanol Production, Corn Oil Production, Agribusiness, and Marketing and Distribution. It produces ethanol and co-products, such as wet, modified wet, or dried distillers grains, in addition to extracts non-edible corn oil that is used as feedstock for biodiesel, livestock feed additives, rubber substitutes, rust preventatives, inks, textiles, soaps, and insecticides.
Prospect Capital Corporation (NASDAQ:PSEC)’s shares dropped -1.53% to $7.50.
Prospect Capital Corporation (PSEC) declared that Prospect has offered Capstone Logistics, LLC (“Capstone”), an existing portfolio company of Prospect, with an incremental $37.5 million of floating rate secured term debt to support Capstone’s acquisition of Pinnacle Workforce Logistics LLC (“Pinnacle”). Prospect holds Capstone’s entire senior second lien facility, which totals about $100 million.
Headquartered in Atlanta, Capstone services over 50 customers at more than 240 facilities across 45 states. Capstone is an outsourced supply-chain-solutions provider offering freight handling services, supply-chain consulting, and administration of distribution centers. Capstone’s workforce solutions allow distribution center operators to outsource non-core labor-intensive elements of their supply chains. The Jordan Company, L.P. purchased Capstone in August 2014.
Prospect Capital Corporation is a business development company. It specializes in middle market, mature, mezzanine finance, later stage, emerging growth, buyouts, recapitalizations, turnaround, growth capital, development, and subordinated debt tranches of collateralized loan obligations, cash flow term loans, and bridge transactions. It also makes real estate investments particularly in multi-family residential real estate asset class. The fund makes secured debt, senior debt, unitranche debt, first-lien and second lien, private debt, mezzanine debt, and equity investments in private and microcap public businesses.
At the end of Friday’s trade, Celgene Corporation (NASDAQ:CELG)‘s shares dipped -0.75% to $117.92.
Celgene Corporation (CELG) declared that during its June meeting the Company’s Board of Directors authorized the repurchase of up to an additional $4.0 billion of the Company’s common stock.
This open-ended program is effective right away. Purchases may be made in the open market or in privately negotiated transactions from time to time, as determined by Celgene’s administration and in accordance with the requirements of the Securities and Exchange Commission. Celgene now has a total of about $5.2 billion remaining from previous authorizations plus the new authorization. Since 2009, Celgene has returned about $12.3 billion to shareholders through the repurchase program.
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally. It markets REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; ABRAXANE, a solvent-free chemotherapy product to treat breast, non-small cell lung, pancreatic, and gastric cancers; POMALYST/IMNOVID for the treatment of multiple myeloma; and VIDAZA, a pyrimidine nucleoside analog to treat intermediate-2 and high-risk MDS, and chronic myelomonocytic leukemia, in addition to acute myeloid leukemia (AML).
Nuance Communications Inc. (NASDAQ:NUAN), ended its Friday’s trading session with -1.88% loss, and closed at $17.75.
Nuance Communications Inc. (NUAN) declared a partnership with Jvion, a healthcare predictive analytics company, to provide further support to healthcare organizations with Advanced Practice Clinical Documentation Improvement™ (CDI) as they prepare for the shift to a value-based reimbursement model. Part of the Nuance Clintegrity 360 solution, Advanced Practice CDI now provides physicians with real-time visibility and guidance into how clinical documentation translates into quality metric scores and appropriate reimbursement. By counting Jvion’s data analytics reports into Advanced Practice CDI, Nuance enables organizations to dive deeper into their own clinical data and pinpoint specific target areas for clinical documentation improvement.
Although the industry is transitioning payment models, many healthcare organizations are not prepared to fully make this shift due to the revenue gap that exists between reimbursement under recently’s fee-for-service system and the changing rules under a value-based payment model. Advanced Practice CDI arms healthcare organizations with actionable insights and data to ensure they are accurately and comprising charting information to capture the severity of their patient populations, case mix index (CMI) and associated levels of care.
Nuance Communications, Inc. provides voice and language solutions for businesses and consumers worldwide. It offers hosted and on-premise solutions and services that provide platforms to generate and distribute clinical documentation through the use of dictation and transcription features; clinical documentation improvement programs; and speech recognition solutions for radiology, cardiology, pathology, and related specialties enabling healthcare providers to dictate, edit, and sign reports without manual transcription. The company also offers mobile and consumer solutions comprising voice control and text-to-speech solutions; dictation applications; text input; mobile messaging services; and Web search and voicemail-to-text services for use in phones, cars, tablets, desktop and portable computers, televisions, smart watches, personal navigation devices, and other consumer electronics.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
